Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Insights
    3. Articles
    4. Demystifying AI in health care — So what is artificial intelligence, anyway?Articles

    Article

    Demystifying AI in health care — So what is artificial intelligence, anyway?

    July 16, 2020

    Share

    By Sarah Swank

    How is artificial intelligence in health care defined? Sarah Swank explores the challenge defining of AI in health care amid a continuously evolving landscape.

    Artificial intelligence (or AI) was pushed into the middle of the COVID-19 pandemic. AI emerged in other industries and started to penetrate the health care market before the novel (new) coronavirus. While it appears the pandemic has pushed us years into the future, we continue to struggle defining AI and the legal guide posts in health care.

    So, what is AI in health care?

    AI is difficult to define. Generally, it is the term for the development of computer algorithms to generate predictive models. But it can also be more. In health care, AI could apply to patient care, medical devices, clinical research, telehealth, and revenue cycle. If successful, AI delivers results reportedly faster and more accurately than humans, and potentially provides real time data or augmented decision making for clinicians. Clearer definitions of AI will likely come with reimbursement and new legal changes.

    But what does that really mean for health care right now?

    As the first telehealth surges and medical offices adjust to COVID-19 exposure risks and shortages of PPE, bots screen for COVID-19 when call centers and offices become overwhelmed. AI also supports vaccine and drug development as well as surge detection and supply movement, which are critical to our fight against the pandemic.

    What does the Food and Drug Administration (FDA) think?

    Last year, the FDA put forward a proposed regulatory framework for medical devices containing AI technology. The FDA defined AI broadly as “the science and engineering of making intelligent machines, especially intelligent computer programs.” The framework focuses on transparency, patient safety, and an ongoing review process as machines “learn.”

    So far, the proposed framework has not changed.

    In February 2020, the FDA held a public workshop with radiologists and others to see how AI and radiological imaging might help identify and treat COVID-19.

    So, what is augmented intelligence in medicine?

    Augmented intelligence is a term adopted by the American Medical Association (AMA). The idea is that in medicine AI focuses on augmenting or enhancing human intelligence rather than replacing it.

    The takeaway — it’s complicated.

    AI is here. And while there is not currently a single definition, they do blend technology, medicine, and law. Even still, these definitions are often inconsistent or unclear, which reflects how it is a complex situation that continues to evolve.

    Artificial IntelligenceHealthcare

    Practices

    Intellectual PropertyHealthcare

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL